()
 
 

Overview

Echo Therapeutics is a transdermal medical device company with deep expertise in advanced skin permeation technology. Echo is developing its PreludeTM SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that will enable two important applications:
Needle-free drug delivery, with the delivery of lidocaine as the first application. Additional applications for painless, needle-free delivery of drugs are planned.
Analyte extraction, with the SymphonyTM tCGM System for needle-free, continuous glucose monitoring in hospital patients as the first application.


Keywords


Stock

Exchange: OTCBB
Industry: Biotechnology/Biopharmaceutical
Market Cap: $108.1M



Contact Information

8 Penn Center
1628 JFK Blvd. Suite 300
Philidelphia, PA 19103

tel: 215-717-4100
fax:
http://www.echotx.com

,



Investor Relations

NationalIR

tel: (888) 925-9119
fax:
e-mail: info@nationalIR.com




e-mail:

No Press Releases

No Upcoming Events

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.